| 47 | | - | SECTION 1. The legislature finds that, according to the federal Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer deaths for men and women in the United States and according to a recent report from the American Lung Association, it is the leading cause of cancer death for men and women in Hawaii. The report also ranks Hawaii last in the nation for the early diagnosis of lung cancer. The legislature further finds that Act 162, Session Laws of Hawaii 2022 (Act 162), established the early lung cancer screening task force within the department of health to research the steps and resources necessary to increase early lung cancer screening in Hawaii. The department of health submitted a January 2023 progress report to the legislature, wherein it indicated that the initial meeting of the task force has been delayed due to changes in leadership in various state and county departments. The task force is projected to be ready for its initial meeting by the end of February 2023; however, the task force is currently set to sunset July 31, 2023. Accordingly, the purpose of this Act is to amend Act 162 to provide the early lung cancer screening task force more time to submit reports to the legislature and ensure the task force can meet in perpetuity as needed to address and reduce the impact lung cancer has on the State's diverse population. SECTION 2. Act 162, Session Laws of Hawaii 2022, section 2, is amended as follows: 1. By amending subsection (c) to read: "(c) The chairperson of the task force shall invite the following individuals to become members of the task force: (1) A representative from the United States Department of Veterans Affairs; (2) A representative from each health insurer operating in the State, including TRICARE; (3) A representative from each health care system operating in the State, including but not limited to The Queen's Health Systems, Hawaii Pacific Health, Kaiser Permanente Hawaii, federally qualified health centers, Native Hawaiian health centers, and Tripler Army Medical Center; (4) A representative from the American Lung Association; (5) A representative from [the American Cancer Society;] an organization that offers services to cancer patients and their families; (6) A representative from the Hawaii Primary Care Association; (7) At least one representative from an organization representing health care providers with relevant expertise on lung cancer screening; and (8) Any other members, including representatives from state agencies, stakeholders, or advocates, as recommended by a majority of the task force." 2. By amending subsections (h), (i), and (j) to read: "(h) The task force shall submit [an] interim [report] reports of its findings and recommendations, including any proposed legislation, to the legislature no later than twenty days prior to the convening of the regular [session] sessions of 2023[.], 2024, and 2025. (i) The task force shall submit a final report of its findings and recommendations, including any proposed legislation, to the legislature no later than July 31, [2023.] 2025. The report shall include: (1) An analysis of the costs associated with early lung cancer screening; (2) A list of qualified facilities in the State that perform lung cancer screenings; (3) Protocols for health care providers and health care systems to identify populations at high risk for lung cancer; (4) An explanation of how health care providers are made aware of available insurance coverage for early lung cancer screenings; (5) Copies of guidelines used by health insurance providers to determine coverage for early lung cancer screening; (6) A discussion of cultural and social barriers associated with lung cancer screenings; (7) Policy recommendations for increasing early lung cancer screenings; and (8) A work plan that identifies the steps needed in the next five years to increase lung cancer screenings in the State. (j) The task force shall cease to exist on [July 31, 2023.] July 31, 2025." SECTION 3. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for fiscal year 2023-2024 for the early lung cancer screening task force established pursuant to Act 162, Session Laws of Hawaii 2022, to carry out its work. The sums appropriated shall be expended by the department of health for the purposes of this Act. SECTION 4. This Act shall take effect on June 30, 3000. |
|---|
| 47 | + | SECTION 1. The legislature finds that, according to the federal Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer deaths for men and women in the United States. According to a recent report from the American Lung Association, lung cancer is the leading cause of cancer death for men and women in Hawaii. The report also ranks Hawaii last in the nation for the early diagnosis of lung cancer. The legislature further finds that Act 162, Session Laws of Hawaii 2022 (Act 162), established the early lung cancer screening task force within the department of health to research the steps and resources necessary to increase early lung cancer screening in Hawaii. The department of health submitted a January 2023 progress report to the legislature, wherein it indicated that the initial meeting of the task force has been delayed due to changes in leadership in various state and county departments. The task force is projected to be ready for its initial meeting by the end of February 2023; however, the task force is currently set to sunset July 31, 2023. Accordingly, the purpose of this Act is to amend Act 162 to provide the early lung cancer screening task force more time to submit reports to the legislature and ensure the task force can meet in perpetuity as needed to address and reduce the impact lung cancer has on the State's diverse population. SECTION 2. Act 162, Session Laws of Hawaii 2022, section 2, is amended as follows: 1. By amending subsection (c) to read: "(c) The chairperson of the task force shall invite the following individuals to become members of the task force: (1) A representative from the United States Department of Veterans Affairs; (2) A representative from each health insurer operating in the State, including TRICARE; (3) A representative from each health care system operating in the State, including but not limited to The Queen's Health Systems, Hawaii Pacific Health, Kaiser Permanente Hawaii, federally qualified health centers, Native Hawaiian health centers, and Tripler Army Medical Center; (4) A representative from the American Lung Association; (5) A representative from [the American Cancer Society;] an organization that offers services to cancer patients and their families; (6) A representative from the Hawaii Primary Care Association; (7) At least one representative from an organization representing health care providers with relevant expertise on lung cancer screening; and (8) Any other members, including representatives from state agencies, stakeholders, or advocates, as recommended by a majority of the task force." 2. By amending subsections (h), (i), and (j) to read: "(h) The task force shall submit [an] interim [report] reports of its findings and recommendations, including any proposed legislation, to the legislature no later than twenty days prior to the convening of the regular [session] sessions of 2023[.] and 2024. (i) The task force shall submit a final report of its findings and recommendations, including any proposed legislation, to the legislature no later than July 31, [2023.] 2024. The report shall include: (1) An analysis of the costs associated with early lung cancer screening; (2) A list of qualified facilities in the State that perform lung cancer screenings; (3) Protocols for health care providers and health care systems to identify populations at high risk for lung cancer; (4) An explanation of how health care providers are made aware of available insurance coverage for early lung cancer screenings; (5) Copies of guidelines used by health insurance providers to determine coverage for early lung cancer screening; (6) A discussion of cultural and social barriers associated with lung cancer screenings; (7) Policy recommendations for increasing early lung cancer screenings; and (8) A work plan that identifies the steps needed in the next five years to increase lung cancer screenings in the State. (j) The task force shall [cease to exist on July 31, 2023.] meet in perpetuity as is needed to reduce the mortality and morbidity rates associated with lung cancer in Hawaii." SECTION 3. There is appropriated out of the general revenues of the State of Hawaii the sum of $250,000 or so much thereof as may be necessary for fiscal year 2023-2024 for the early lung cancer screening task force established pursuant to Act 162, Session Laws of Hawaii 2022, to carry out its work. The sums appropriated shall be expended by the department of health for the purposes of this Act. SECTION 4. This Act shall take effect on July 1, 2023. INTRODUCED BY: _____________________________ |
|---|